Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma
Michel Bila, Amelie Franken, Jeroen Van Dessel, Melisa Garip, Jeroen Meulemans, Robin Willaert, Ann Hoeben, Vincent Vander Poorten, Paul M. Clément
Topics & Concepts
MedicineDiscontinuationHead and neck squamous-cell carcinomaAdverse effectInternal medicineOncologyPopulationRetrospective cohort studyHead and neck cancerCancerEnvironmental healthCancer Immunotherapy and BiomarkersHead and Neck Cancer StudiesInflammatory Biomarkers in Disease Prognosis